Immunotherapy combo shows promise against tough throat cancer
Disease control
Completed
This study tested whether adding the immunotherapy drug nivolumab to standard chemoradiation helps patients with stage II to IVB nasopharyngeal cancer. Forty adults with this type of throat cancer took part. The main goal was to see if patients could complete all planned treatmen…
Phase: PHASE2 • Sponsor: Sue Yom • Aim: Disease control
Last updated May 26, 2026 12:09 UTC